LITERATURE ALERTS

LITERATURE ALERTS

• A computer-based expert system designs and analyzes a 2(k -p) fractional factorial design for the formulation optimization of novel multicomponent liposomes. LOUKAS, Y. L. J. Pharm. Biomed. Anal., 1998, 17 (1), 133–140.
   PubMedGoogle Scholar
• A microencapsulated lewis acid. A new type of polymer-supported lewis acid catalyst of wide utility in organic synthesis. KOBAYASHI, S., and NAGAYAMA, S. J. Am. Chem. Soc., 1998, 120 (12), 2985–2986.
   Google Scholar
• A new internal gelation process for fuel microsphere preparation without cooling initial solutions. YAMAGISHI, S. J. NucL Mater., 1998, 254 (1), 14–21.
   Google Scholar
• A nanosecond fluorescence study of the simultaneous influx of Ca2+ and Cd2+ into liposom es. HIRSHFIELD, K. M., TOPTYGINT, D., GRANDHIGE, G., PACKARD, B. Z., and BRAND, L. Biophys. Chem., 1998, 71 (1), 63–72.
   Google Scholar
• A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) micro-spheres using agarose hydrogel. WANG, N., and Wu, X. S. Int. J. Pharm., 1998, 166 (1), 1–14.
   Google Scholar
• A novel plasma factor initiating complement activation on cetylmannoside-modified lipo-somes in human plasma. ISHIDA, T., imA, S., FUNATO, K., and KIWADA, H. Int. J. Pharm., 1998, 164 (1-2), 91–102.
   Google Scholar
• A study on accuracy of rCBF measurements loaded with acetazolamide based on the microsphere model using iodine-123-IMP SPECT. OHKUBO, M., ODANO, I., Nocucm, E., Ourmu, H., SHIBAKI, M., DOBASHI, Y., and Yoxoi, T. Kaku Igaku, 1998, 35 (3), 147–151.
   PubMedGoogle Scholar
• Alginate-based microcapsules for immunoprotected islet transplantation. SIEBERS, U., HORCHER, A., BRETZEL, R. G., PEDERLIN, K., and ZEKORN, T. Ann. N. Y. Acad. Sd., 1997, 831, 304–312. 25 Refs.
   Google Scholar
• Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisola-fion in diabetic recipients. CALAFIORE, R., BASTA, G., LUCA, G., BOSELLI, C., BUFALARI, A., GmsTozzi, G. M., Mocci, L., and BRUNETTI, P. Ann. N. Y. Acad. Sci., 1997, 831, 313–322. 15 Refs.
   Google Scholar
• Amitogenic alginates: key to first clinical application of microencapsulation technology. HASSE, C., ZIELKE, A., KLOCK, G., ScrmossEE, A., BARTH, P., ZIMMERMANN, U., SITTER, H., LORENZ, W., and ROTHMUND, M. World J. Surg., 1998, 22 (7), 659–665.
   Google Scholar
• An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. KOLTOVER, I., SALDITT, T., RADLER, J. 0., and SAFINyA, C. R. Science, 1998, 281 (5373), 78–81.
   PubMedGoogle Scholar
• Antibacterial reactive liposomes encapsulating coupled enzyme systems. JoNts, M. N., HILL, K. J., KASZUBA, M., and CREETH, J. E. Int. J. Pharm., 1998, 162 (1-2), 107–117.
   Google Scholar
• Antioxidative activities of several marine polysaccharides evaluated in a phosphatidylcho-line-liposomal suspension and organic solvents. XUE, C., Yu, G., HIRATA, T., TERAO, J., and LIN, H. Biosci., Biotechnol., Biochem., 1998, 62 (2), 206–209.
   Google Scholar
• Antitumor effect of polysaccharide coated liposom al adriamycin on AH66 hepatom a in nude mice. ICHINOSE, K., YAMAMOTO, M., KHOJI, T., Ism', N., SUNAMOTO, J., and KANEMATSU, T. Anticancer Res., 1998, 18 (1A), 401–404.
   Google Scholar
• Application of HPLC to counting of colored microspheres in determination of regional blood flow. MAZOIT, J. X., LE, G. R., DECAUX, A., ALBALADEJO, P., and SAMII, K. Am. J. PhysioL, 1998, 274 (3, Pt. 2), H10414–11047.
   Google Scholar
• Application of noninvasive biophysical techniques for the determination of cutaneous hydration capacity of PML liposomes. I. MART', E., CEMELI, J., and DEL-Pozo, A. Cienc. Pharm., 1998, 8 (1), 31–37.
   Google Scholar
• Application of high-velocity fluidized bed reactor for producing hollow inorganic micro-spheres from volcanic glass particles. UEMURA, Y., NEZU, S., HAMAKAWA, N., I.pcm, K., OnzuNo, Y., and HATATE, Y. J. Chem. Eng. Jpn., 1998, 31 (2), 298–301.
   Google Scholar
• Application of liposom es for development of oral vaccines: stability of liposom es in vitro, and the serum and intestinal hum oral immune responses of mice to orally administered antigen in liposomes. HAN, M., WATARAI, S., YASUDA, T., and KODAMA, H. Drug Delivery Syst., 1998, 13 (1), 13–20.
   Google Scholar
• Avidin-biotin immobilization of unilamellar liposomes in gel beads for chromatographic analysis of drug-membrane partitioning. YANG, Q., Lm, X. Y., AJIKI, S.-I., HARA, M., LUNDAHL, P., and MIYAKE, J. J. Chromatogr., B: Biomed. Sci. AppL, 1998, 707 (1+ 2), 131–141.
   Google Scholar
• beta-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale. WRIGHT, M. J., ROSENTHAL, E., STEWART, L., WIGHTMAN, L. M. L., MILLER, A. D., LATCHMAN, D. S., and MARBER, M. S. Gene Ther., 1998, 5 (3), 301–308.
   Google Scholar
• Bioadhesive liposomes bearing levonorgestrel as controlled drug delivery system. UPPADHYAY, A. K., and DIXIT, V. K. Pharmazie, 1998, 53 (6), 421–422.
   PubMed Web of Science ®Google Scholar
• Bioavailability and pharm acokinetics of microencapsulated 1,3-dichloropropene in rats. STOTT, W. T., GILBERT, J. R., MCGUIRK, R. J., BRZAK, K. A., ALEXANDER, L. M., DRYZGA, M. D., MENDRALA, A. L., and BARTELS, M. J. TOICiCOL SCL, 1998, 41 (1), 21–28.
   Google Scholar
• Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. GUPTA, R. K., CHANG, A. C., and SIBER, G. R. Dev. Biol. Stand., 1998, 92 (Modulation of the Immune Response to Vaccine Antigens), 63–78.
   Google Scholar
• Biodegradation of poly(ethylene adipate)microcapsules in physiological media. ATKINS, T. W. Biomaterials, 1998, 19 (1-3), 61–67.
   PubMed Web of Science ®Google Scholar
• Biological membranes and liposomes protect red blood cell (RBC) against trifluoperazine-induced hem olysis. MALHEIROS, S. V. P., MEIRELLES, N. C., ZAIKOV, G. E., TATARSKAYA, N. K., and DEGTEREV, I. A. ax-id. Commun., 1998, 21 (1), 127–134.
   Google Scholar
• Bordetella pertussis filamentous hem agglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally. POULAIN, G. 0., MIELCAREK, N., IvANG, N., REMOUE, F., SCHACHT, A. M., PHILLIPS, N., LOCHT, C., CAPRON, A., and RIVEAU, G. Infect. Immtat., 1998, 66 (4), 1764–1767.
   PubMedGoogle Scholar
• Bridging nerve defects with differently treated muscle grafts: assessment of microsphere technique for measurement of blood flow in rats. WANG, Y., HUNG, L. K., and LEUNG, P. C. Chin. Med. J. (Engl.), 1997, 110 (10), 774–777.
   PubMedGoogle Scholar
• Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. STAHL, W. JUNGHANS, A., DE-BOER, B., DRIOMNA, E. S., ElniviBA, K., and SIES, H. FEBS Lett., 1998, 427 (2), 305–308.
   Google Scholar
• Cascade liposom al triggering: light-induced Ca2+ release from diplasmenylcholine lipo-somes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes. WYMER, N. J., GERASIMOV, 0. V., and THOMPSON, D. H. Bioconjugate Chem., 1998, 9 (3), 305–308.
   PubMedGoogle Scholar
• Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. MEYER, 0., KIRPOTIN, D., HONG, K., STERNBERG, B., PARK, J. W., WOODLE, M. C., and PAPAHADJOPOULOS, D. J. Biol. Chem., 1998, 273 (25), 15621–15627.
   PubMed Web of Science ®Google Scholar
• Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. PORTER, C. D., LUKACS, K. V., Box, G., TAKEUCHI, Y., and COLLINS, M. K. L. Virol., 1998, 72 (6), 4832–4840.
   Google Scholar
• Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. THURSTON, G., MCLEAN, J. W., RIZEN, M., BALUK, P., HASKELL, A., MURPHY, T. J., HANAHAN, D., and McDONALD, D. M. J. Clin. Invest., 1998, 101 (7), 1401–1413.
   PubMedGoogle Scholar
• Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha v-integrins. QIU, C., DE-YOUNG, M. B., FINN, A., and DICHEK, D. A. Hum. Gene Ther., 1998, 9 (4), 507–520.
   PubMedGoogle Scholar
• Cationic liposomes in gene delivery. YOTSUYANAGI, T., and HAZEMOTO, N. Nippon Rinsho, 1998,56 (3), 705–712. 38 Refs.
   Google Scholar
• Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery. IEnamoLo, R. M., ROSSANESE, A., ROTILIO, A., MATTISI, G., GERUNDA, G. E., MERENDA, R., NERI, D., CREPALDI, G., and STRAZZABOSCO, M. J. HepatoL, 1998, 28 (3), 518–522.
   Google Scholar
• Changes of liposomes electrophoretic mobility under the effect of ribonuclease and cyto-chrome c. GORBENKO, G. P., KURILKO, S. A., and MALYKHINA, T. V. Biofizika, 1998, 43 (2), 260–263.
   PubMedGoogle Scholar
• Characterization of a new ocular delivery system based on a dispersion of liposomes in a therm osensifive gel. BOCHOT, A., PATTAL, E., GROSSIORD, J. L., PUISIEUX, F., and COUVREUR, P. Int. J. Pharm., 1998, 162 (1-2), 119–127.
   Google Scholar
• Characterization of a pH-sensitive surfactant, dodec y1-2-(1'-im idazoly1) propionate (DIP), and preliminary studies in liposome mediated gene transfer. LIANG, E., and HUGHES, J. Biochim. Biophys. Acta., 1998, 1369 (1), 39–50.
   PubMedGoogle Scholar
• Characterization of bovine serum factor triggering the lysis of liposomes via complement activation. Liu, S., IsHIDA, T., and KIWADA, H. Biol. Pharm. Bull., 1998, 21 (4), 390–397.
   PubMedGoogle Scholar
• Chemiluminescence property of the luminol-hydrogen peroxide-copper (II) system in the presence of surface-carboxylated microspheres. TSUKAGOSHI, K., SUMIYAMA, M., NAKA JIMA, R., NAKAYAMA, M., and MAEDA, M. Anal. Sci., 1998, 14 (2), 409–412.
   Google Scholar
• Chemotherapy with hybrid liposomes for cancer. An experimental study. KANN°, A., KODAMA, R., TERADA, Y., MATSUMOTO, Y., and UEOKA, R. Drug Delivery Syst., 1998, 13 (2), 101–105.
   Google Scholar
• Clearance properties ofliposom es involving conjugated proteins for targeting. HARASYM, T. 0., BALLY, M. B., and TARDI, P. Adv. Drug Delivery Rev., 1998,32 (1, 2), 99–118.
   Google Scholar
• Coating of POPC giant liposomes with hydrophobized polysaccharide. UEDA, T., LEE, S. J., NAKATANI, Y., OURISSON, G., and SUNAMOTO, J. Chem. Lett., 1998, (5), 417–418.
   Google Scholar
• Cognitive dysfunction induced by whole body (neutron-gam m a) irradiation in the rat: effect of liposome-entrapped Cu/Zn bovine superoxide dismutase. LAMPROGLOU, I., MARTIN, S., DELATTRE, J. Y., FESSI, H., PUISIEUX, F., COLAS-L1NHART, N., FATOME, M., and MARTIN, C. Chim. Phys. Phys.-Chim. Biol., 1998, 95 (4), 804–807.
   Google Scholar
• Colon epithelium can be transiently transfected with liposomes, calcium phosphate pre-cipitation, and DEAE dextran in vivo.@ LIPTAY, S., WEIDENBACH, H., ADLER, G., and SCHMID, R. M. Digestion, 1998, 59 (2), 142–147.
   PubMedGoogle Scholar
• Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. CABANES, A., BRIGGS, K. E., GOKHALE, P. C., TREAT, J. A., and RAHMAN, A. int.OncoL, 1998, 12 (5),1035–1040.
   PubMedGoogle Scholar
• Comparison of intraurethral liposom al and intracavernosal prostaglandin-El in the manage-ment of erectile dysfunction. ENGELHARDT, P. F., PLAS, E., HUBNER, W. A., and PFLUGER, H. Br. J. UroL, 1998, 81 (3), 441–444.
   Google Scholar
• Comparison of skin anesthetic effect of liposom al lidocaine, nonliposomal lidocaine, and EMLA using 30-minute application time. BUCALO, B. D., MIRIKITANI, E. J., and Moy, R. L. Dermatol. Surg., 1998, 24 (5), 537–541.
   Google Scholar
• Comparison between intratracheal and intravenous administration of liposome-DNA com-plexes for cystic fibrosis lung gene therapy. GRIESENBACH, U., CHONN, A., CASSADY, R., HANNAM, V., ACKERLEY, C., POST, M., TANSWELL, A. K., OLEK, K., 0 BRODOVICH, H., and Tsui, L. C. Gene Ther., 1998, 5 (2), 181–188.
   PubMedGoogle Scholar
• Competitive mechanisms in the hepatic uptake of liposomes in vivo. SHIMADA, T., HARASHIMA, H., and KIWADA, H. Yakuzaigaku, 1997, 57 (4), 197–203.
   Google Scholar
• Controlling liposome blood clearance by surface-grafted polymers. WOODLE, M. C. Adv. Drug Delivery Rev., 1998, 32 (1, 2), 139–152.
   Google Scholar
• Coronary vascular bed perfusion with a polyethylene glycol-modified hemoglobin-encapsu-lated liposome, Neo red cell, in rats. NAKAI, K., USUBA, A., OHTA, T., KUWABARA, M., NAKAZATO, Y., MOTOKI, R., and TAKAHASHI, T. A. Artif. Organs, 1998, 22 (4), 320–325.
   Google Scholar
• Cross-flow filtration-an improved detergent removal technique for the preparation of liposomes. PESCHKA, R., PURMANN, T., and SCHUBERT, R. Int. J. Pharm., 1998, 162 (1-2), 177–183.
   Google Scholar
• Cutting edge: liposom al formulation of a self lymphoma antigen induces potent protective antitumor immunity. KWAK, L. W., PENNINGTON, R., Bo, L., OCHOA, A. C., ROBB, R. J., and POPESCU, M. C. J. Immunol., 1998, 160 (8), 3637–3641.
   Google Scholar
• Cytokine imm unotherapy of cancer with controlled release biodegradable microspheres in a hum an tumor xenograft/SCID mouse model. EGILMEZ, N. K., JoNG, Y. S., IWANUMA, Y., JACOB, J. S., SANYos, C. A., CHEN, F. A., YE --ATHIOWITZ, E., and BANKERT, R. B. Cancer Immunol. Immtatother., 1998, 46 (1), 21–24.
   Google Scholar
• Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. CROXFORD, J. L., TRIANTAPHYLLOPOULOS, K., PODHAJCER, 0. L., FELDMANN, M., BAKER, D., and CHERNAJOVSKY, Y. J. Immunol., 1998, 160 (10), 5181–5187.
   PubMed Web of Science ®Google Scholar
• Degradation of porous poly(anhydride-co-imide) microspheres and implications for con-trolled macromolecule delivery. HANES, J., CHIBA, M., and LANGER, R. Biomaterials, 1998, 19 (1-3), 163–172.
   PubMed Web of Science ®Google Scholar
• Delivery of ivermectin by injectable microspheres. MILLER, J. A., OEHLER, D. D., and POUND, J. M. J. Econ. EntomoL, 1998, 91 (3), 655–659.
   PubMedGoogle Scholar
• Design and development of controlled release of drugs from injectable microcapsules. TAKADA, S., and OGAWA, Y. Nippon Rinsho, 1998, 56 (3), 675–679. 18 Refs.
   Google Scholar
• Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer micro-spheres. GuErA, R. K., GRIN, P. JR, RIVERA, R., and SIBER, G. R. Dev. Biol. Stand., 1998, 92, 277–287.
   PubMedGoogle Scholar
• Development of liposom al anthracyclines: from basics to clinical applications. GABIZON, A., GoREN, D., COHEN, R., and BARENHOLZ, Y. J. Controlled Release, 1998, 53 (1-3), 275-279. Development in liposome-amplified immunoassay. WANG, F., CHANG, W., and CI, Y. Fenxi Huaxue, 1998, 26 (3), 351–358.
   Google Scholar
• Dielectric analysis of polystyrene microcapsules using scanning dielectric microscope. AsAN11, K. Colloid Polym. Sci., 1998, 276 (4), 373–378.
   Google Scholar
• Direct formation of mixed micelles in the solubilization of phospholipid liposomes by Triton X-100. LOPEZ, 0., DE LA MAZA, A., CODERCH, L., LopEz, I. C., WEHRLI, E., and PARRA, J. L. FEBS Lett., 1998, 426 (3), 314–318.
   PubMedGoogle Scholar
• Direct gene transfer into the rat pancreas using DNA-liposomes. SCHMID, R. M., WEIDIINBACH, H., YAMAGUSHI, H., LUHRS, H., LIPTAY, S., and ADLER, G. Eur. Clin. Invest., 1998, 28 (3), 220–226.
   PubMedGoogle Scholar
• Drugs, in cyclodextrins, in liposomes: a novel approach to the chemical stability of drugs sensitive to hydrolysis. LOUKAS, Y. L., VRAKA, V., and GREGORIADIS, G. Int. J. Pharm., 1998, 162 (1-2), 137–142.
   Google Scholar
• Drugs-in-cyclodextrins-in-liposom es: an approach to controlling the fate of water insoluble drugs in vivo. MCCORMACK, B., and GREGORIADIS, G. Int. J. Pharm., 1998, 162 (1-2), 59–69.
   Google Scholar
• Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveifiS. POUVREAU, I., ZECH, J. C., THILLAYE- GOLDENBERG, B., NAUD, M. C., VAN ROOIJEN, N., and DE KOZAK, Y. J. NeuroimmunoL, 1998,86 (2), 171–181.
   PubMed Web of Science ®Google Scholar
• Effect of interparticulate interaction on release kinetics of microsphere ensembles. Wu, X. Y., EsHuN, G., and ZHou, Y. J. Pharm. Sci., 1998, 87 (5), 586–593.
   PubMedGoogle Scholar
• Effect of dose and release rate on pulmonary targeting of liposom al triamcinolone acetonide phosphate. SUAREZ, S., GONZALEZ, R. R. J., SCHREIER, H., and HOCHHAUS, G. Pharm. Res., 1998, 15 (3), 461–465.
   PubMed Web of Science ®Google Scholar
• Effect of emulsifier blend on the characteristics of sustained release diclofenac micro-spheres. LEWIS, L., Bo, R., and ADEYEYE, C. M. J. Microencapsulation, 1998, 15 (3), 283–298.
   PubMedGoogle Scholar
• Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11. SADZUKA, Y., HIROTSU, S., and HIROTA, S. Cancer Lett. (Shannon, Irel. ), 1998, 127 (1,2), 99–106.
   Google Scholar
• Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice. MOSER, C. A., SPEAKER, T. J., and OEHT, P. A. J. ViroL, 1998, 72 (5), 3859–3862.
   Google Scholar
• Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. Dm, L. Y and WAN, L. S. C. J. Microencapsulation, 1998, 15 (3), 319–333.
   PubMedGoogle Scholar
• Effects of cholesterol liposome on cytoskeleton of rabbit sphincter of Oddi cells in culture. ZHANG, J., WE', J., ZHANG, M., WANG, D., SHI, Y., and Ji, Z. Disi Junyi Daxue Xuebao, 1997, 18 (6), 528–531.
   Google Scholar
• Effects of prostaglandin El incorporated in liposomes on blood pressure in rats. Li, X., Xu, L., ZHANG, L., and DILINUER. Shanxi Yike Daxue Xuebao, 1997, 28 (4), 243–244.
   Google Scholar
• Efficacy and safety of liposom al am photericin B (Am Bisome) for visceral leishmaniasis in endemic developing countries. BERMAN, J. D., BADARO, R., THAKUR, C. P., WAsuNNA, K. M., BEHBEHANI, K., DAVIDSON, R., KUZOE, F., PANG, L., WEERASURIYA, K., and BRYCESON, A. D. Bull. World Health Organ., 1998, 76 (1), 25–32.
   Google Scholar
• Efficient detection of single molecules eluting off an optically trapped microsphere. MACHARA, N. P., GOODWIN, P. M., ENDERLEIN, J., SEMIN, D. J., and KELLER, R. A. Bioirnaging, 1998, 6 (1), 33–42.
   Google Scholar
• Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing. FIFE, K., BOWER, M., COOPER, R. G., STEWART, L., ETHERIDGE, C. J., Coomms, R. C., BULUWELA, L., and MILLER, A. D. Gene Ther., 1998, 5 (5), 614–620.
   PubMedGoogle Scholar
• Enhanced antitumor effects of interleukin-2 liposomes in C57BL/6N mice with B-16 mela-noma pulmonary metastases. WEI, H., and ilk, Z. Mianyixue Zazhi, 1997, 13 (3), 14.4–148.
   Google Scholar
• Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. ABE, A., MiyANoHAEA, A., and FRIEDMANN, T. J. ViroL, 1998, 72 (7), 6159–6163.
   PubMed Web of Science ®Google Scholar
• ESR study of the liposome membrane physical parameters in the heating-cooling cycles. P000LAu, M., MAN, D., and PRZESTALSKI, S. Z Naturforsch, C Biosci., 1998, 53 (3/4), 191–196.
   Google Scholar
• Evaluation of liposomes encapsulating nimustine prepared with a pH gradient method. YAMADA, N., OKOCHI, H., ARIMORI, K., NAKANO, M., GOTO, T., KITAMURA, I., KOCHI, M., and UsHio, Y. Drug Delivery Syst., 1998, 13(1), 41–46.
   Google Scholar
• Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. AKIYAMA, Y., NAGAHARA, N., NARA, E., KITANO, M., IWASA, S., YAMAMOTO, I., AZUMA, J., and OGAwA, Y. J. Pharm. PharmacoL, 1998, 50 (2), 159–166.
   PubMedGoogle Scholar
• Evidence for intrinsic Kerr bistability of high-Q microsphere resonators in superfluid helium. TREUSSART, F., ILCHENKO, V. S., ROCH, J. F., HARE, J., LEFEVRE, S. V., RAIMOND, J. M., and HAROCHE, S. Eur. Phys. J. D., 1998, 1 (3), 235–238.
   Google Scholar
• Experimental studies for screening the factors that influence the effectiveness of new multicomponent and protective liposomes. LOUKAS, Y. L. Anal. Chim. Acta, 1998, 361 (3), 241–251.
   Google Scholar
• Extractability of metal ions with polyethyleneimine microcapsules. WATARAI, H., ASAKI, M., and FUKUMOTO, T. Solvent Extr. Res. Dev., Jpn., 1998, 5, 106–115.
   Google Scholar
• Fabrication of three-dimensional macroporous membranes with assemblies of microspheres as templates. PARK, S. H., and XIA, Y. Chem. Mater., 1998, 10 (7), 1745–1747.
   Google Scholar
• Flow cytometric analysis of cellular changes in mice after intraderm al inoculation with a liposome-iscom adjuvanted vaccine. GIL, F. S., TURNER, B., MULLBACHER, A., WALKER, M. J., DJORDJEVIC, S. P., EAmENs, G. J., and CHIN, J. C. Scand. J. ImmunoL, 1998, 47 (3), 243–253.
   Google Scholar
• Fracture of composites prepared from polystyrene and glass microspheres. SANCHEZ, M., VELASCO, J. I., DIAZ, M. R., FERRER, D., and MORHAIN, C. Rev. Plast. Mod., 1998,75 (501), 257–260.
   Google Scholar
• From mixed micelles to liposomes: critical steps during detergent removal by membrane dialysis. WACKER, M., and SCHUBERT, R. Int. J. Pharm., 1998, 162 (1-2), 171–175.
   Google Scholar
• Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres. UN, S. Y., CHEN, K. S., and TENG, H. H. J. Microencapsulation, 1998, 15 (3), 383–390.
   PubMedGoogle Scholar
• Fusogenic liposome directs an exogenous antigen into class I major histocompatibility complex antigen-presenting pathway. NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., HAYAKAWA, T., and MAYUMI, T. Drug Delivery Syst., 1998, 13 (1), 27–33.
   Google Scholar
• Fusogenic liposome functions as an efficient im muno-adjuvant in inducing humoral immune-responses to soluble antigen. KUNISAWA, J., NAKANISHI, T., HAYASHI, A., TSUTSUMI, Y., HAYAKAWA, T., and MAYUMI, T. Drug Delivery Syst., 1998, 13 (1), 21–26.
   Google Scholar
• Gene transduction for disseminated intraperitoneal tumor using cationic liposom es contain-ing non-histone chromatin proteins: cationic liposomal gene therapy of carcinoma-tosa. NAMIKI, Y., TAKAHASHI, T., and OHNO, T. Gene Ther., 1998, 5 (2), 240–246.
   PubMedGoogle Scholar
• Gene introduction into animal tissues by fusogenic liposomes. NAKANISHI, M. Nippon Rinsho, 1998, 56 (3), 713–717. 7 Refs.
   Google Scholar
• Generation of metal nanoparticles by laser ablation of microspheres. CAI, H., CHAUDHARY, N., LEE, J., BECKER, M. F., BROCK, J. R., and KETO, J. W. J. Aerosol Sci., 1998, 29 (5/6), 627–636.
   Google Scholar
• GHRH Agonist. Horm one-suppressive effects of monthly microcapsule-depot form of GHRH agonist, leuprorelin. SUDO, K., and OGAWA, Y. Cell ( Tokyo), 1998, 30 (4), 146–149.
   Google Scholar
• Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposom al liver-specific contrast agent for CT. HOGLUND, P., LEANDER, p., HUSTVEDT, S. 0., KLOSTER, Y., and BORSETH, A. Acad. RadioL, 1998, 5 Suppl 1, S47-S48; discussicn S60–S62.
   Google Scholar
• HVJ (Sendai virus) liposome-mediated gene transfer: current status and future perspectives (review). YONEMITSU, Y., ALTON, E. W., KOMORI, K., YOSHIZUMI, T., SUGIMACHI, K., and KANEDA, Y. Int. .1. OncoL, 1998, 12 (6), 1277–1285. 58 Refs.
   Google Scholar
• Hydration of polyethylene glycol-grafted liposomes. TIROSH, 0., BARENHOLZ, Y., KATZHENDLER, J., and PRIEV, A. Biophys. J., 1998, 74 (3), 1371–1379.
   PubMedGoogle Scholar
• Identification of proteins mediating clearance of liposom es using a liver perfusion system. HARASHIMA, H., MATSU°, H., and KIWADA, H. Adv. Drug Delivery Rev., 1998, 32 (1,2), 61–79.
   Google Scholar
• Imaging experimental osteomyelitis using radiolabeled liposomes. AWASTHI, V., COINS, B., KLIPPER, R., LOREDO, R., KORVICK, D., and PHILLIPS, W. T. .1. NucL Med., 1998, 39 (6), 1089–1094.
   Google Scholar
• Immobilized liposome and biomembrane partitioning chromatography of drugs for predic-tion of drug transport. BEIGI, F., GOTTSCHALK, I., LAGERQUIST, H. C., HANESKOG, L., BREKKAN, E., ZHANG, Y., OSTERBERG, T., and LUNDAHL, P. int. .1. Pharin., 1998, 164 (1–2), 129–137.
   Google Scholar
• Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers. CHAICUMPA, W., CHONGSA-NGUAN, M., KALAMBAHETI, T., WILAIRATANA, p., SRIMA-NOTE, P., MAKAKUNKIJCHAROEN, Y., LOOAREESUWAN, S., and SAKOLVAREE, Y. Vaccine, 1998, 16 (7), 678–684.
   PubMedGoogle Scholar
• Improved nuclear magnetic resonance microscopic visualization of joint cartilage using liposome entrapped contrast agents. GRUNDER, W., BIESOLD, M., WAGNER, M., and WERNER, A. Invest. Radiol., 1998, 33 (4), 193–202.
   PubMedGoogle Scholar
• Improvement of transduction efficiency of recombinant adeno-associated virus vector by entrapment in multilamellar liposom es. MIZUNO, M., and YOSHIDA, J. Jpn. J. Cancer Res., 1998, 89 (4), 352–354.
   PubMedGoogle Scholar
• In situ time response measurement of the microspheres dispersed in electrorheological fluids. WEN, W., ZHING, D. W., and Tu, K. N. Phys. Rev. E: Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top., 1998, 57 (4), 4516–4519.
   Google Scholar
• In vitro and in vivo evaluation of insulin-producing beta TC6-F7 cells in microcapsules. Znou, D., SUN, A. M., Li, X., MAMUJEE, S. N., VACEK, I., GEORGIOU, J., and WHEELER, M. B. Am. J. PhysioL, 1998, 274 (5 Pt 1), C1356–C1362.
   Google Scholar
• In vitro characterization of methotrexate-loaded poly(lactic acid) microspheres of different molecular weights. SINGH, U. V., and UDUPA, N. Drug Delivery, 1998, 5 (1), 57–61.
   PubMedGoogle Scholar
• In vitro evaluation of the mucoadhesive properties of chitosan microspheres. HE, P., DAVIS, S. S., and ILLum, L. Int. J. Pharm., 1998, 166 (1), 75–88.
   Google Scholar
• In vitro studies of liposome encapsulated anti-HIV agents: a new approach in AIDS therapy? Beshkov, D., Gabev, E. E., Gabev, E. B., and ARGLROVA, R. ProbL Infect. Parnsit. Div., 1997, 24 (1), 8–9.
   Google Scholar
• In vitro gene transfer in mammalian cells via a new cationic liposome formulation. KAo, M. C., LAw, S. L., CHUANG, T. C., and UN, Y. S. OncoL Rep., 1998, 5 (3), 625–629.
   Google Scholar
• Incorporation of oc-tocopherol in dimyristoylphosphatidylcholine liposomes improves the survival of fibroblasts in culture. BERROCAL, M. C., BUJAN, J., and ABEGER, A. Drug Delivery, 1998, 5 (1), 19–24.
   PubMedGoogle Scholar
• Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable micro-spheres along with alum. DIWAN, M., DAWAR, H., and TALWAR, G. P. Prostate, 1998, 35 (4), 279–284.
   PubMedGoogle Scholar
• Influence ofliposome bilayer fluidity on the transport of encapsulated substance into the skin as evaluated by EPR. VRHOVNIK, K., KRISTL, J., SENTJURC, M., and SMID, K. J. Pharm. Res., 1998, 15 (4), 525–530.
   PubMedGoogle Scholar
• Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique. UGWOKE, M. I., and KINGET, R. J. Microencapsulation, 1998, 15 (3), 273–281.
   PubMedGoogle Scholar
• Influence of manufacturing parameters on the size characteristics and the release profile of ketoprofen from spray-dried poly(o, L-lactic-co-glycolic acid) microspheres. ERTL, B., WIRTH, M., AUINGER, P., and GABoR, F. ScL Pharm., 1998, 66 (2), 107–117.
   Google Scholar
• Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats.
   Google Scholar
• ZHANG, W., Guo, L., NADEL, J. A., and PAPAHADJOPOULOS, D. Pharm. Res., 1998, 15 (3), 455–460.
   Google Scholar
• Interaction of sugar with phospholipid bilayer—study on the stabilization of liposom es. TONG, Q., and ME, S. Sheng Li Ko Hsueh Chin Chan, 1996, 27 (2), 123–128. 16 Refs.
   Google Scholar
• Interaction of recombinant interleukin-2 with liposom al bilayers. KOPPENHAGEN, F. J., VISSER, A. J., HERRON, J. N., STORM, G., and CROMMELIN, D. J. J. Pharm. Sci., 1998, 87 (6), 707–714.
   Google Scholar
• Interactions between liposomes and human skin in vitro, a confocal laser scanning micro-scopy study. VAN KUIJK, M. M. E. M. J., JUNGINGER, H. E., and BOUWSTRA, J. A. Biochim. Biophys. Acta, 1998, 1371 (1), 31–39.
   PubMedGoogle Scholar
• Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behavior in vivo. SEMPLE, S. C., CHONN, A., and CuLus, P. R. Adv. Drug Delivery Rev., 1998,32 (1,2), 3–17.
   Google Scholar
• Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. EYLES, J. E., SHARP, G. J., WILLIAMSON, E. D., SPIERS, I. D., and ALPAR, H. 0. Vaccine, 1998, 16 (7), 698–707.
   Google Scholar
• Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. YANASE, M., SHINKAI, M., HONDA, H., WAKABAYASHI, T., YOSHIDA, J., and KOBAYASHI, T. Jpn. J. Cancer Res., 1998, 89 (4), 463–469.
   Google Scholar
• Intracellular and serum stability of liposom al 2',3'-dideoxycytidine. Effect of lipid composi-tion. MAKABI, P. B., GOURDE, p., DESORMEAUX, A., and BERGERON, M. G. Cell. MoL Biol. (Paris), 1998, 44 (2), 277–284.
   Google Scholar
• Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. VALERO, F., HAMON, M., FOURNIER, C., MEURICE, T., FLAUTRE, B., BELLE, E. V., LABLANCHE, J. M., GOSSELIN, B., BAUTERS, C., and BERTRAND, M. J. Cardiovasc. Pharniacol., 1998, 31 (4), 513–519.
   PubMedGoogle Scholar
• Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. TEN, H. T. L. M., VAN VIANEN, W, SAVELKOUL, H. F. J., HEREMANS, H., BlanDLAN, W. A., and BAKKER WOUDENBERG, I. A. J. M. Infect. Immun., 1998, 66 (5), 1962–1967.
   Google Scholar
• Is liposom al am photericin B (am bisom e) an effective prophylaxis of mycotic infections after liver transplantation? Braun, F., Ruchel, R., Lorf, T., Canelo, R., Muller, A., Sattler, B.RINGE, B. Transplant. Proc., 1998, 30 (4), 1481–1483.
   PubMed Web of Science ®Google Scholar
• Lateral diffusion of the total polar lipids from Therm oplasm a acidophilum in multilamellar liposomes. JARRELL, H. C., ZUKOTYNSKI, K. A, AND SPROTT, G. D. Biochim. Biophys. Acta, 1998, 1369 (2), 259–266.
   PubMedGoogle Scholar
• Lipophilic drug derivatives in liposomes. GULATI, M., GROVER, M., SINGH, S., and SINGH, M. Int. J. Pharm., 1998, 165 (2), 129–168.
   Google Scholar
• Liposomal delivery of a 30-mer antisense oligodeoxynucleotide to inhibit proopiomelano-corfin expression. FRESTA, M., CHILLEMI, R., SPAMPINATO, S., SCIUTO, S., and PUGLISI, G. Pharm. Sri., 1998, 87 (5), 616–625.
   Google Scholar
• Liposomal transfection efficiency and toxicity on glioma cell lines: in vitro and in vivo studies. BELL, H., KIMBER, W. L., Li, M., and WHITTLE, I. R. NeuroReport, 1998, 9 (5), 793–798.
   PubMedGoogle Scholar
• Liposomal amphotericin B: therapeutic use in the management of fungal infections and visceral leishmaniasis. COUKELL, A. J., and BROGDEN, R. N. Drugs, 1998,55 (4), 585–612.
   Google Scholar
• Liposomal tacrolim us: drug migration within blood compartments. MCALISTER, V. C. Trans-plant. Proc., 1998, 30 (4), 1000–1001.
   PubMedGoogle Scholar
• Liposome encapsulated hemoglobin as a resuscitation fluid for hemorrhagic shock. USUBA, A., OSUKA, F., KIMURA, T., SATO, R., FUJITA, Y., YAMASHITA, M., and HOSHINO, C. Artif. Organs, 1998,22 (2), 116–122.
   PubMedGoogle Scholar
• Liposome-based immunomigration assays. ROBERTS, M. A., and DURST, R. A. Methods Biotech-nol., 1998, 7 (Affinity Biosensors), 187–207.
   Google Scholar
• Liposome-encapsulated muram yl tripeptide phosphatidylethanolamine (L-MTP-PE): a ran-domized clinical trial in dogs with mammary carcinoma. TESKE, E., RUTTEMAN, G. R., V-D INGH, T. S., VAN NOORT, R., and MISDORP, W. Anticancer Res., 1998, 18 (2A), 1015–1019.
   Google Scholar
• Liposome-mediated gene transfer into established CNS cell lines, primary glial cells, and in vivo. KOFLER, p., WIESENHOFER, B., REHRL, C., BAIER, G., STOCKHAMMER, G., and HUMPEL, C. Cell Transplant, 1998, 7 (2), 175–185.
   Google Scholar
• Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen. RICHARDS, R. L., RAO, M., WASSEF, N. M., GLENN, G. M., ROTHWELL, S. W., and ALVING, C. R. Infect. Immun., 1998, 66 (6), 2859–2865.
   Google Scholar
• Liposomes: quo vadis? STORM, G., and CROMMELIN, D. J. A. Pharrn Sci. TechnoL Today, 1998,1 (1), 19–31.
   Google Scholar
• Local treatment of prosthetic vascular graft infection with multivesicular liposome-encap-sulated am ikacin. HUH, J., CHEN, J. C., FURMAN, G. M., MALKI, C., KING, B., KAFIE, F., and WILSON, S. E. J. Surg. Res., 1998, 74 (1), 54–58.
   PubMedGoogle Scholar
• Manipulation of Kupffer cells by liposome encapsulated clodronate and propamidine-synergistic and antagonistic effects of liposom al phospholipids and drugs. VAN ROEIJEN, N., and SANDERS, A. Int. J. Pharm., 1998, 162 (1-2), 51–58.
   Google Scholar
• Manufacture and in vitro characterization of a new liquid theophylline sustained release dosage form. Sachets with microcapsules for the preparation of a ready-to-use sus-tained release suspension. WEISS, G., KLEMM, F. H., FucHs, W. S., STANISLAUS, F., ZEMA, M., and CALANCHI, M. Arzneim Forsch, 1998, 48 (5a), 604–612.
   Google Scholar
• Methyl-13-cyclodextrins and liposom es as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymic fluorescence assay and membrane fluidity-sensitive dyes. HARTEL, S., DIEHL, H. A., and FLAVIO, 0. S. Anal. Biochem., 1998, 258 (2), 277–284.
   Google Scholar
• Methylprednisolone in bilayer liposom es prolongs cardiac, and renal allograft survival, inhibits macrophage activation,, and selectively modifies antigen presentation, and T-helper cell function in rat recipients. BINDER, J., BRAEUTIGAM, R., OERTL, A., KRAMER, W., JONAS, D., HANCOCK, W. W., and KUPIEC WEGLINSKI, J. W. Transplant PrOC., 1998,30 (4), 1051.
   Google Scholar
• Microcapsules as bio-organs for somatic gene therapy. CHANG, P. L. Ann. N. Y. Acad. Sci., 1997, 831, 461–473. 25 Refs.
   Google Scholar
• Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study. HELLE, S. I., GEISLER, J., FOULSEN, J. p., HESTDAL, K., MEADOWS, K., COLLINS, W., TVEIT, K. M., HOLLY, J. M., and LONNING, P. E. Br. J. Cancer, 1998, 78 (1), 14–20.
   Google Scholar
• Microencapsulation of the renin inhibitor FK906 by phase separation of ethyl cellulose in c yclohe xane. WEISS, G., YAMAGUCHI, H., IBuici, R., YASUMURA, M., and °FINISH', N. J. Microencapsulation, 1998, 15 (3), 335–346.
   PubMedGoogle Scholar
• Microencapsulation of cells. Medical applications. SUN, A. M. Ann. N. Y. Acad. Sci., 1997, 831, 271–279. 29 Refs.
   Google Scholar
• Microencapsulation of living Bifidobacterium. Li, W., ZHANG, L., and YANG, R. Guangdong Yaoxueyuan Xuebao, 1997, 13 (4), 222–225.
   Google Scholar
• Microencapsulation of marine oils with a view to food fortification. Ni, N. M. E., and YOUNGER, K. M. Spec. PubLR. Soc. Chem., 1998, 215 (Functional Foods), 149–158.
   Google Scholar
• Microsphere-induced bronchial artery vasodilation: role of adenosine, prostacyclin, and nitric oxide. FEARSE, D. B., DAHMS, T. E., and WAGNER, E. M. Am. J. PhysioL, 1998, 274 (3, Pt. 2), H760–H768.
   Google Scholar
• Microspheres containing plasm id-encoded antigens elicit cytotoxic T-cell responses. HEDLEY, M. L., CURLEY, J., and URBAN, R. Nat. Med. (N. Y.), 1998, 4 (3), 365–368.
   PubMedGoogle Scholar
• Modeling specific heat transient anomalies during permeation ofliposom es by water-soluble substances. RAUDINO, A., and CASTELLI, F. J. Colloid Interface Sci., 1998, 200 (1), 52–58.
   Google Scholar
• Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide micro-spheres. WALKER, K. B., XING, D. K., SESARDIC, D., and CORBEL, M. J. Dev. Biol. Stand., 1998, 92, 259–267.
   PubMedGoogle Scholar
• Morphological observations on liposomes bearing covalently bound protein: studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques. SKALKO, N., BOUVvSTRA, J., SPIES, F., STUART, M, FREDERIK, P. M., and GREGOR-IADIS, G. Biochim. Biophys. Acta, 1998, 1370 (1), 151–160.
   PubMedGoogle Scholar
• Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(o, t-lactide-co-glycolide) microspheres. ALLAOUL A. K., FATTAL, E., FECQUET, S., TROLLE, S., CHACHATY, E., COUVREUR, p., and ANDREMONT, A. Vaccine, 1998, 16 (7), 685–691.
   Google Scholar
• Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunor-ubicin: implications for liposome-encapsulated daunorubicin. YERDONCK, L. F., LOKHORST, H. M., ROOVERS, D. J., and VAN HEUGTEN, H. G. Leulc. Res., 1998, 22 (3), 249–256.
   Google Scholar
• Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen. CHILDERS, N. K., TONG, G., and MICHALEK, S. M. Oral MicrobioL InvntaioL, 1997, 12 (6), 329–335.
   Google Scholar
• Neonatal porcine islets as a possible source of tissue for humans and microencapsulation improves the metabolic response of islet graft posttransplantation. KORBUTT, G. S., Ao, Z., FLASIINER, M., and RAJOTTE, R. V. Ann. N.Y. Acad. Sci., 1997, 831, 294–303. 52 Refs.
   Google Scholar
• New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety. LEANDER, P., HOGLUND, P., KLOSTER, Y., and BORSETH, A. Acad. Radiol., 1998, 5 (Suppl 1), S6-S8; discussicn S28–S30.
   Google Scholar
• New strategies for the microencapsulation of tetanus vaccine. SCHWENDEMAN, S. P., TOBIO, M., JOWOROWICZ, M., ALONSO, M. J., and LANGER, R. J. Microencapsulation, 1998, 15 (3), 299–318.
   Google Scholar
• Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. Clio, N. H., SEONG, S. Y., CHUN, K. H., Km, Y. H., CHAN, K. I., AHN, B. Y., and JEoNc, S. Y. J. Controlled Release, 1998, 53 (1-3), 215–224.
   Google Scholar
• Novel preparation of asymmetric liposomes with inner and outer layer of different materi-als. XIAO, Z., HUNAG, N., Xu, M., Lu, Z., and WEI, Y. Chem. Lett., 1998, (3), 225–226.
   Google Scholar
• Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. AEoNsoHN, A. I., and HUGHES, J. A. J. Drug Target., 1998, 5 (3), 163–169.
   PubMedGoogle Scholar
• Opsono-recognition of liposomes by tissue macrophages. MocHimi, S. M. Int. J. Pharm., 1998, 162 (1–2), 11–18.
   Google Scholar
• Oral and nasal immunization with microencapsulated clinically relevant proteins. ALPAR, H. 0., EYLEs, J. E., and WILLIAMSON, E. D. S TP Pharma. Sci., 1998, 8 (1), 31–39.
   Google Scholar
• Ovalbumin coupled either with murine red blood cells or liposome induces IgG but not IgE antibody production. UCHIDA, T., NAITO, S., HORINO, A., TANEICHI, M., MIZUGUCHI, J., NAKANO, Y., OKA, T., OOKUMA, K., MOROKUMA, K., SAKURAI, S., and KOMURO, K. Dev. Biol. Stand., 1998, 92, 353–363.
   PubMedGoogle Scholar
• Ovalbumin peptide encapsulated in poly(ot-lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. NEWMAN, K. D., SAMUEL, J., and KWON, G. J. Controlled Release, 1998, 54 (1), 49–59.
   PubMedGoogle Scholar
• PEG-liposome in DDS and clinical studies. MARUYAMA, K. Nippon Rfrisho, 1998, 56 (3), 632–637. 17 Refs.
   Google Scholar
• Pegylated liposomal doxorubicin (DOXIL, CAELYX) distribution in tumor models observed with confocal laser scanning microscopy. USTER, P. S., and YAAGE, J. Int. J. Pharm., 1998, 162 (1-2), 77–86.
   Google Scholar
• Permeation control of polymerized liposome with various surfactants. CHUNG, Y. C. Bull. Korean Chem. Soc., 1998, 19 (3), 284–285.
   Google Scholar
• Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. HIRANO, T., FUJIMOTO, J., UEKI, T., YAMAMOTO, H., IWASAKI, T., MORISITA, R., SAWA, Y., KANEDA, Y., TAKAHASHI, H., and OKAMOTO, E. Gene Ther., 1998, 5 (4), 459–464.
   PubMedGoogle Scholar
• pH-sensitive release of indomethacin using lactan-acetate microspheres. NA, K., and LEE, K. Y. Drug Dev. Ind. Pharm., 1998, 24 (6), 563–568.
   PubMedGoogle Scholar
• pH-sensitive, cationic liposomes: a new synthetic virus-like vector. BUDKER, Y., GUREVICH, Y., HAGSTROM, J. E., BORTZOV, F., and WOLFF, J. A. Nat. Biotechnol., 1996, 14 (6), 760–764.
   Google Scholar
• Pharmacokinetics and anti-inflammatory activity of liposome-entrapped superoxide dismu- tase. TONG, R., YE, S., and Lu, B. Zhongguo Yaolixue Yu Dulixue Zazhi, 1997, 11 (3), 235–236.
   Google Scholar
• Phase transformation of a liposomal dispersion into a micellar solution induced by drug-loading. SCHUTZE, W., and MULLER, G. C. C. Pharm. Res., 1998, 15 (4), 538–543.
   PubMedGoogle Scholar
• Photooxidative damage of skin lipids in liposomes: (hSCLLs)-interference of sterols with the lipid peroxidafion chain. LASCH, J., SCHONFELDER, U., WALKE, M., ZELLMER, S., and BECKERT, D. Int. J. Pharm., 1998, 162 (1-2), 129–136.
   Google Scholar
• Physical aging of progesterone-loaded poly(o,t,-lactide-co-glycolide) microspheres. Rositio, V., DEYmE, M., BENOIT, J. P., and MADELMONT, G. Pharm. Res., 1998, 15 (5), 794–798.
   Google Scholar
• Physical stability of size controlled small unilamellar liposomes coated with a modified poly(vinyl alcohol). TAKEUCHI, H., YAMAMOTO, H., TOYODA, T., TOYOBUKU, H., HINT°, T., and KAWASHIMA, Y. Int. J. Pharm., 1998, 164 (1-2), 103–111.
   Google Scholar
• Physicochemical specification of drug carrying liposomes for the quality control in the industrial production. HIROTA, S. Int. J. Pharm., 1998, 162 (1-2), 185–194.
   Google Scholar
• Polymeric microspheres. KAwAcuctu, H. Shikizai Kyokaishi, 1998,71 (4), 272–279.
   Google Scholar
• Porous monodisperse poly(divinylbenzene) microspheres by precipitation polymerization. Li, W. H., and STOVER, H. D. H. J. Polym. Sci., Part A: Polym. Chem., 1998, 36 (10), 1543–1551.
   Google Scholar
• Potential efficacy of gelatin microspheres as a new adjuvant for oral vaccination. NAKAMURA, M., YAMASHITA, S., TSUME, Y., NADAI, T., SEZAKI, H., KOHN°, T., TABATA, Y., and IKADA, Y. STP Pharma. Sci., 1998,8 (1), 67–73.
   Google Scholar
• Preclinical evaluation of a sterically stabilized liposome-encapsulated cisplatin in clinically normal cats. THAMM, D. H., and VAIL, D. M. Am. J. Vet. Res., 1998, 59 (3), 286–289.
   PubMedGoogle Scholar
• Preferential hydrolysis of oxidized phosphatidylcholine in cholesterol-containing phospha-tidylcholine liposome by phospholipase A2. KAMBAYASHI, Y., YAMAMOTO, Y., and NAKANO, M. Biochem. Biophys. Res. Commun., 1998, 245 (3), 705–708.
   PubMedGoogle Scholar
• Preparation of polyurethane microcapsules by interfacial polycondensation. FRERE, Y., DANI-CHER, L., and GnAmmN, P. Eur. Polym. J., 1998, 34 (2), 193–199.
   Google Scholar
• Preparation of crack-free porous glass microspheres with high strength. Xu, M., and YUAN, Q. Wuhan Gongye Daxue Xuebao, 1997, 19 (3), 18–20.
   Google Scholar
• Preparation and characterization of bifunctional biopolymers for receptor-based liposomal im m unosensing. Yu, Y. Y., VAN WIE, B. J., KocH, A. R., Mom, D. F., and DAvis, W. C. Biotechnol. Prog., 1998, 14 (2), 310–317.
   Google Scholar
• Preparation and application on volunteers of two experimental series trivalent subunit liposome influenza vaccine. KAVAKLOVA, L., KOTSEVA, R., and VALKOVA, B. Probl. Infect. Parasit. Dis., 1997, 24 (2), 8–9.
   Google Scholar
• Preparation and evaluation of sustained release crosslinked chitosan microspheres contain-ing phenobarbitone. AL HELW, A. A., AL ANGARY, A. A., MAHROUS, G. M., and AL DARDARI, M. M. J. Microencapsulation, 1998, 15 (3), 373–382.
   Google Scholar
• Preparation of biodegradable PLA-PEG copolymer microspheres with micron sizes. Li, X., MAO, J., Li, X., XIONG, C., and DENG, X. Gaofenzi Cailiao Kexue Yu Gongcheng, 1998, 14 (3), 20–22.
   Google Scholar
• Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solu-tions. ANDRIANOV, A. K., CHEN, J., and PAYNE, L. G. Biomaterials, 1998, 19 (1-3), 109–115.
   PubMedGoogle Scholar
• Preparation of two dosage forms containing antitumor prostaglandin, and their antitumor effect in vitro and in vivo: Lipiodol solution for i.a. administration and lipid micro-spheres for i.p. or i.v. administration. Sligo, F., MASAHIRO, N., YOSHIKAZU, T., and MAsANom, F. Adv. Exp. Med. Biol., 1997, 400B, 955–961.
   PubMedGoogle Scholar
• Preparation of liposomes by a controlled assembling method. ZHANG, L. G., Hu, J. C., and Lu, Z. H. Huaxue Xuebao, 1998, 56 (4), 335–339.
   Google Scholar
• Preparation of porous glass microspheres as adsorption carriers. CAO, Z., ZHANG, X., ZHAO, Z., and Li, L. Lizi Jiaohuan Yu Xifu, 1998, 13 (6), 579–582.
   Google Scholar
• Preparation of superoxide dismutase from bovine blood and its gelatin microcapsules. D., ZHANG, Z., YE, M., and ZHANG, T. Zhongguo Shenghua Yaowu Zazhi, 1998, 19 (1), 6–11.
   Google Scholar
• Preparation of targeted isoniazid microspheres. BOSELA, A. A., ELSAYED, M. M., and MAHMOUD, M. I. Boll. Chim. Farm., 1998, 137 (3), 77–81.
   Google Scholar
• Production of polyethylene glycol and polyoxyalkylene alkylphenyl ether microspheres using supercritical carbon dioxide. MISHIMA, K., MATSUYAMA, K., TARUTA, Y., EZAWA, M., ITO, Y., and NAGATANI, M. Stud. Surf Sci. CataL, 1998, 114 (Advances in Chemical Conversicns for Mitigating Carbon Dioxide), 661–664.
   Google Scholar
• Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposom e. Li, X. K., OKUYAMA, T., TAMURA, A., FUJIN°, M., FUNESHIMA, N., KANEDA, Y., KITA, Y., ENOSAWA, S., AMEMIYA, H., and Suzuni, S. Transplant. Proc., 1998, 30 (4), 943.
   Google Scholar
• Protein encapsulation and release from poly(lactide-co-glycolide)microspheres. Effect of the protein and polymer properties and of the co-encapsulation of surfactants. BLANCO, D., and ALoNso, M. J. Eur. J. Pharm. Biopharm., 1998, 45 (3), 285–294.
   Google Scholar
• Protein encapsulation in biodegradable am phiphilic microspheres. I. Polymer synthesis and characterization and microsphere elaboration. BOUILLOT, P., PETIT, A., and DELLACHERIE, E. J. AppL Polym. Sci., 1998, 68 (10), 1695–1702.
   Google Scholar
• Protein-induced CF release from liposomes in vitro and its correlation with the BLOOD/RES biodistribution of liposomes. PANAGI, Z., AVGOUSTAKIS, K., EVANGELATOS, G., and ITHAKIS-SIOS, D. S. Int. J. Pharm., 1998, 163 (1-2), 103–114.
   Google Scholar
• Pulmonary disease models induced by in vivo hem agglutinating virus of Japan liposome-mediated en dothelin-1 gene transfer. TAKEDA, S. I., Mnrosin, S., °mom, K. I., UTSUMI, T., KOGAKI, S., SAWA, Y., YANAGISAWA, M., and MATSUDA, H. J. Cardiovasc. Pharmacol., 1998, 31 (Suppl. 1, Endothelin V), S336–S338.
   Google Scholar
• Radioembolization with 32P-labelled glass microspheres for advanced hepatocellular carci-noma. YAN, L., Li, L., and CHEN, S. Chung Hua Wai Ko Tsa Chih, 1996,34 (9), 526–529.
   Google Scholar
• Raman spectroscopic study of microcosmic and photosensitive damage on the liposomes of the mixed phospholipids sensitized by hypocrellin and its derivatives. YIMING, X., HONGXIA, Z., and Zum, Z. J. Photochem. Photobiol., B, 1998, 43 (1), 41–46.
   Google Scholar
• Receptor versus non-receptor mediated clearance of liposomes. SCHERPHOF, G. L., and KAMPS, J. A. A. M. Adv. Drug Delivery Rev., 1998,32 (1,2), 81–97.
   Google Scholar
• Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) micro-spheres. Influence of the encapsulation technique and polymer purity on microsphere characteristics. BITTNER, B., MORLOCK, M., KOLL, H., WINTER, G., and KISSEL, T. Eur. J. Pharm. Biopharm., 1998, 45 (3), 295–305.
   Google Scholar
• Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. SAARI, S. M., VIDGREN, M. T., KOSKINEN, M. 0., TURJANMAA, V. M., WALDREP, J. C., and NIEMINTEN, M. M. Chest, 1998, 113 (6), 1573–1579.
   PubMedGoogle Scholar
• Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex. MASUDA, Y., KOBAYASHI, H., HOLLAND, J. F., and OHNUMA, T. Cancer Chemother. Pharmacol., 1998, 42 (1), 9–16.
   PubMedGoogle Scholar
• Rhinocerebral zygomycosis treated with liposom al amphotericin B and surgery. SALTOGLU, N., TACSOVA, Y., ZORLUDEMIR, S., and DUNDAR, I. H. Mycoses, 1998, 41 (1-2), 45–49.
   Google Scholar
• Saccharide-assisted delivery of cytotoxic liposomes to human malignant cells. VODOVOZOVA, E. L., GAYENKO, G. P., RAZINTKOV, V. I., KORCHAGINTA, E. Y., BOVIN, N. V., and MOLOTKOVSKY, J. G. Biochem. MoL Biol. Int., 1998, 44 (3), 543–553.
   Google Scholar
• Selected aspects of the microencapsulation of mammalian cells in HEMA-MMA. SEFTON, M. V., HWANG, J. R., and BABENSEE, J. E. Ann. N. Y. Acad. Sci., 1997, 831, 260–270.
   PubMedGoogle Scholar
• Selective labeling of the inner liposome leaflet by fluorescent lipid probes, and studies of liposome fusion with influenza virus. HERNANDEZ, J. E. I., RAZINKOV, V. I., MIKHALY0V, I. I., KOZMINYKH, A. V., COHEN, F. S., and MOLOTKOVSKY, J. G. Membr. Cell. Biol., 1997,11 (4), 515–527.
   PubMedGoogle Scholar
• Selective targeting of Kupffer cells with liposom al butyrate augments portal venous transfu-sion-induced im munosuppression. PEREZ, R. V., JonNsoN, J., HUBBARD, N. E., ERICKSON, K., MORGAN, M., KIM, S., RUDICH, S. M., KATZNELSON, S., and GERMAN, J. B. Transplantation, 1998, 65 (10), 1294–1298.
   Google Scholar
• Self-healing composites using embedded microspheres. JUNG, D., HEGEMAN, A., SOTTOS, N. R., GEUBELLE, P. H., and WHITE, S. R. MD (Am. Soc. Mech. Eng.), 1997, 80 (Composites and Functicnally Graded Materials), 265–275.
   Google Scholar
• Separation of serum proteins with uncoupled microsphere particles in a stirred cell. YOON, J. Y., LEE, J. H., KIM, J. H., and KIM, W. S. Colloids Surf, B, 1998, 10 (6), 365–377.
   Google Scholar
• Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system. The concept of tissue specificity. MocHimi, S. M., and PATEL, H. M. Adv. Drug Delivery Rev., 1998, 32 (1,2), 45–60.
   Google Scholar
• Shear plane and hydrodynamic diameter of microspheres in suspension. XU, R. Langmuir, 1998, 14 (10), 2593–2597.
   Google Scholar
• Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasm id DNA-liposome complex. ImAoxA, T., DATE, I., OHMOTO, T., and NAGATSU, T. Hum. Gene Ther., 1998, 9 (7), 1093–1102.
   PubMedGoogle Scholar
• Solubilization of liposom es modeling the stratum corneum lipid composition by betaine-type zwitterionic surfactants. DE LA MAZA, A., CODERCH, L., LopEz, 0., and PARRA, J. L. Colloids Surf, A, 1998, 136 (3), 273–280.
   Google Scholar
• Spontaneous emission from fluorescent molecules embedded in photonic crystals consisting of polystyrene microspheres. YAMASAKI, T., and TSUTSUI, T. AppL Phys. Lett., 1998,72 (16), 1957–1959.
   Google Scholar
• Stability of alpha-amylase immobilized on poly(methyl methacrylate-acrylic acid) micro-spheres. AKSOY, S., TUMTURK, H., and HASIRCI, N. J. Biotechnol., 1998, 60 (1,2), 37–46.
   Google Scholar
• Stability of dithranol in cream, stick, and liposom al bases. THOMA, K., and HOLZMANN, C. Pharm. Ind., 1998, 60 (4), 359–367.
   Google Scholar
• Stabilization of DMPC-liposom es by neutral polymers. GROHMANN, F. L., and CSEMPESZ, F. Magy. Kem. Foly., 1998, 104 (2), 53–59.
   Google Scholar
• Stealth liposom al tumor necrosis factor-alpha in solid tumor treatment. VAN DER VEEN, A. H., EGGERMONT, A. M. M., and TEN HAGEN, T. L. M. Int. J. Pharm., 1998, 162 (1-2), 87–94.
   Google Scholar
• Structural and metabolic consequences of liposome-lipoprotein interactions. RODRIGUEZA,W. V., PHILLIPS, M. C., and WILLIAMS, K. J. Adv. Drug Delivery Rev., 1998, 32 (1,2), 31–43.
   Google Scholar
• Studies on hyperthermia combined with arterial therapeutic blockade for treatment of tumors: (Part III) Effectiveness of hyperthermia combined with arterial chemoembo- lization using degradable starch microspheres on advanced liver cancer. MURATA, T., AnAm, K., IMAMURA, M., NASU, R., KIMURA, H., NAGATA, K., and TANAKA, Y. OncoL Rep., 1998, 5 (3), 709–712.
   Google Scholar
• Studies on hyperthermia combined with arterial blockade for treatment of tumors: (Part II) effectiveness of hyperthermia combined with arterial embolization using degradable starch microsphere S. MURATA, T., AKAGI, K., IMAMURA, M., NASU, R., KIMURA, H., NAGATA, K., and TANAKA, Y. OncoL Rep., 1998, 5 (3), 705–708.
   Google Scholar
• Study on magnetic microspheres for purging cancer cells from bone marrow. II. preparation of polystyrene magnetic microspheres. KANG, J., and WEI, S. Yawcue Xuebao, 1997, 32 (7), 536–541.
   Google Scholar
• Study on the process of copper-microencapsulating on the surface of hydrogen storage alloys. ZHANG, D., YUAN, H., WANG, G., and ZHANG, Y. Dianyuan Jishu, 1998, 22 (3), 111–114.
   Google Scholar
• Sublytic effects caused by C14-alkyl betaine/sodium dodecyl sulfate mixtures in liposomes modeling the stratum corneum lipid composition. DE LA MAZA, A., I3Aucems, J., GONZA-LEZ, P., and PARRA, J. L. Colloids Surf, A, 1998, 133 (3), 253–260.
   Google Scholar
• Surface-modified amikacin-liposomes: organ distribution and interaction with plasma pro-teins. BUCKE, W. E., LEITZKE, S., DIEDERICHS, J. E., BORNER, K., HAHN, H., EHLERS, S., and MULLER, R. H. J. Drug Target., 1998, 5 (2), 99–108.
   Google Scholar
• Synthesis of core-shell type microsphere with reactive seed microspheres. SAITO, R., Ni, X., ImumunA, A., and Ismzu, K. J. AppL Polym. Sci., 1998, 69 (2), 211–216.
   Google Scholar
• Synthetic strategies for the preparation of precursor polymers and of microcapsules suitable for cellular entrapment by polyelectrolyte com plexation of those polymers. DYAKONOV, T. A., ZHOU, L., WAN, Z., HUANG, B., MENG, Z., Guo, X., ALEXANDER, H., MOORE, W. 17.5 and STEVENSON, W. T. Aim. N.Y. Acad. Sci., 1997, 831, 72–85. 15 Refs.
   Google Scholar
• Targeting delivery of liposom al adriamycin by intra-lymphatic infusion. EENG, B., LANG, J., and Li, D. Chung Hua Fu Chan Ko Tsa Chih, 1997, 32 (3), 156–158.
   Google Scholar
• Targeting immune response induction with cochleate and liposome-based vaccines. GOULD, F. S., KHEIRI, M. T., ZHANG, F., WANG, Z., SCOLPINTO, A. J., EEKETEOVA, E., CANKI, M., MANNINO, R. J. Adv. Drug Delivery Rev., 1998, 32 (3), 273–287.
   Google Scholar
• Targeting to lymph nodes by subcutaneous administration of liposomes. OUSSOREN, C., and STORM, G. Int. J. Pharm., 1998, 162 (1-2), 39–44.
   Google Scholar
• Temperature-dependent associating property of liposomes modified with a therm osensitive polymer. HAYASHI, H., KONO, K., and TAKAGISHI, T. Bioconjug. Chem., 1998, 9 (3), 382–389.
   PubMedGoogle Scholar
• The complement system in liposome clearance: can complement deposition be inhibited? DEviNE, D. V., and BRADLEY, A. J. Adv. Drug Delivery Rev., 1998, 32 (1, 2), 19–29.
   Google Scholar
• The covalent coupling of Arg-Gly-Asp-containing peptides to liposomes: purification and biochemical function of the lipopeptide. GYONGYOSSY, I. M. I. C., MULLER, W., and DEVINE, D. V. Arch. Biochem. Biophys., 1998, 353 (1), 101–108.
   PubMedGoogle Scholar
• The effect of an antiphlogistic incorporated in liposomes on experimentally induced inflam-m afion. SCHRAMLOVA, J., BLAZEK, K., OTOVA, B., BARTACKOVA, 1\4.5 and HULINSKA, D. Folia. Biol. (Praha), 1997, 43 (5), 195–199.
   PubMedGoogle Scholar
• The C-terminal helix of human apolipoprotein All promotes the fusion of unilamellar liposomes and displaces apolipoprotein Al from high-density lipoproteins. LAMBERT, G., DECOUT, A., VANLOO, B., ROUY, D., DUVERGER, N., KALOPISSIS, A., VANDEKERCKHOVE, J., CHANmAz, J., BRASSEUR, R., and RosseNuu, M. Eur. J. Biochem., 1998, 253 (1), 328–338.
   Google Scholar
• The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients. AUSTIN, R. P., BARTON, p., DAVIS, A. M., MANNERS, C. N., and STANSFIELD, M. C. J. Pharm. Sci., 1998, 87 (5), 599–607.
   Google Scholar
• The effects of jet nebulization on cationic liposome-m ediated gene transfer in vitro. STERN, M., SORGI, F., HUGHES, C., CAPLEN, N. J., BROWNING, J. E., MIDDLETON, P. G., GRUENERT, D. C., FARR, S. J., HUANG, L., GEDDES, D. M., and ALTON, E. W. F. W. Gene Ther., 1998, 5 (5), 583–593.
   PubMedGoogle Scholar
• The immunological co-adjuvant action of liposom al interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles. GURSEL, M., and GREGORIADIS, G. J. Drug Target., 1998, 5 (2), 93–98.
   PubMedGoogle Scholar
• The inhibitory effect of water-soluble and liposom al beta-carotene on various models of carcinogenesis. ALEKSANDROV, V. A., BESPALOV, V. G., PETROV, A. S., and AVTUSHENKO, S. S. Vopr. Onkol., 1998, 44 (1), 79–85.
   Google Scholar
• The macrophage as target or obstacle in liposome-based targeting strategies. VAN ROOIJEN, N., and SANDERS, A. Int. J. Pharm., 1998, 162 (1-2), 45–50.
   Google Scholar
• The oxidative stabilities of polyunsaturated fatty acids in salmon egg phosphatidylcholine liposomes. NARA, E., MIYASHITA, K., OTA, T., and NADACHI, Y. Fish. Sci., 1998, 64 (2), 282–286.
   Google Scholar
• The preparation of Dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. STENEKES, R. J. H., FRANSSIN, 0., VAN BOMMEL, E. M. G., CROMMELIN, D. J. A., and HENNENTE, W. E. Pharm. Res., 1998, 15 (4), 557–561.
   PubMedGoogle Scholar
• The stability of heparin-coated liposomes in plasma and their effect on its coagulation. SAHLI, A., CANSELL, M., TAPON BRETAUDIERE, J., LETOURNEUR, D., JOZEFONVICZ, J., and FISCHER, A. M. Colloids Surf, B, 1998, 10 (4), 205–215.
   Google Scholar
• The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. BEI, R., GUPTILL, V., MASUELLI, L., KASHMIR', S. V., MURARO, R., PRAT', L., SCHLOM, J., and KANTOR, J. J. Immunother., 1998, 21 (3), 159–169.
   Google Scholar
• The use of India ink and 51Cr-labeled microspheres in examining the function of the yolk stalk as a passageway between the yolk sac and intestine in posthatch broiler chicks. PEEBLES, E. D., SULAIMAN, A., KELLOGG, T. F., MASLIN, W. R., WHITMARSH, S. K., GERARD, P. D. Paull. ScL, 1998, 77 (5), 722–727.
   Google Scholar
• The HVJ liposom e method. ISAKA, Y., AKAGI, Y., KANEDA, Y., and ImAL E. Exp. NephroL, 1998, 6 (2), 144–147.
   PubMedGoogle Scholar
• The molecular design of enzyme-loaded liposomes. ANNESINI, M. C. Chem. Biochem. Eng. Q., 1998, 12 (1), 1–17.
   Google Scholar
• The structure of DNA complexes with cationic liposomes-cylindrical or flat bilayers? DAN, N. Biochim. Biophys. Acta, 1998, 1369 (1), 34–38.
   PubMedGoogle Scholar
• Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. PAPISOV, M. I. Adv. Drug Delivery Rev., 1998,32 (1,2), 119–138.
   Google Scholar
• Theoretical analysis of shape transformations of liposom es caused by microtubule assembly. UMEDA, T., NAKAJIMA, H., and HOTANI, H. J. Phys. Soc. Jpn., 1998, 67 (2), 682–688.
   Google Scholar
• Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by colon 26 or B-16 melanoma in mice. HAGIWARA, A., SAKAKURA, C., SHIRASU, M., YAMASAKI, J., TOGAWA, T., TAKAHASHI, T., MURANISHI, S., HYON, S. H., and IEADA, Y. Anti Cancer Drugs, 1998, 9 (3), 287–289.
   Google Scholar
• Thermal expandable microcapsule Expancel useful in water-based wallpapers. HATANO, Y. Konbatekku, 1998, 26 (3), 20–21.
   Google Scholar
• Thermo-responsive microcapsules using poly(N-isopropylacrylamide). KIDCHOB, T., KIMURA, S., and ImANisHi, Y. Kobunshi Ronbunshu, 1998, 55 (4), 192–199.
   Google Scholar
• Time-dependent maturation of cationic liposome-DNA complex for serum resistance. YANG, J. P., and HUANG, L. Gene Ther., 1998, 5 (3), 380–387.
   PubMedGoogle Scholar
• Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. HOFFMAN, R. M. J. Drug Target., 1998, 5 (2), 67–74. 26 Refs.
   Google Scholar
• Towards the predictability of drug-lipid membrane interactions: the pH-dependent affinity of propranolol to phosphatidylinositol containing liposomes. KRAMER, S. D., BRAUN, A., JAKITS, D. C., and WUNDERLI, A. H. Pharm. Res., 1998, 15 (5), 739–744.
   Google Scholar
• Toxicity of liposom al 3'-5'-0-dipalmitoy1-5-fluoro-21-deoxyuridine in mice. VAN BORSSUM, W. M., GORIS, H., DoNTJE, B. H., SCHWENDENER, R. A., SCHERPHOF, G., and NIJHOF, W. Anticancer Drug Des., 1998, 13 (4), 291–305.
   Google Scholar
• Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy. ISHIDA, 0., and MARUYAMA, K. Nippon Rinsho, 1998, 56 (3), 657–662. 16 Refs.
   Google Scholar
• Ultrasound scattering properties of Albunex microspheres. TAKAMOTO, T., and SHIINA, T. Nippon Rinsho, 1998, 56 (4), 871–875.
   PubMedGoogle Scholar
• Unilamellar lipid bilayers containing cholesterol in wool bleaching: stability of chlorine liposomes. DE LA MAZA, A., MANICH, A. M., CODERCH, L., and PARRA, J. L. AQEIC BoL Tec., 1998,49 (1), 18–29.
   Google Scholar
• Vancomycin release from blended polyester microspheres. ATKINS, T. W., and YATES, D. J. Drug Delivery, 1998, 5 (1), 63–71.
   PubMedGoogle Scholar
• Virosom es: cationic liposomes enhance retroviral transduction. HODGSON, C. p., and SOLAIMAN, F. Nat. BiotechnoL, 1996, 14 (3), 339–342.
   PubMedGoogle Scholar
• Vitamin E improves the uptake of unsaturated soya lecithin liposomes by human fibroblasts in vitro. BERROCAL, M. C., BUJAN, J., JURADO, F., and ABEGER, A. Microencap.szdation, 1998,15 (3), 347–359.
   Google Scholar